Join
Live feed
·
PRReleasevia Quantisnow
Astria Therapeutics Inc. logo

Astria Therapeutics Announces Exclusive Worldwide License Agreement with Ichnos Sciences for OX40 Portfolio

ByQuantisnow·Wall Street's wire, on your screen.
ATXS· Astria Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATXS (Astria Therapeutics Inc.) and more on Quantisnow.